Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Preci Health SA operates a company patent portfolio in the Medical Devices & Mechanical Engineering sector. The portfolio shows 2 pending office actions, which are assigned to 1 distinct examiner. This examiner, HOEKSTRA, JEFFREY GERBEN, is the busiest examiner for the portfolio and is responsible for 2 busiest examiner pending actions. All prosecution activity is currently localized within 1 distinct art unit, reflecting the technical consistency in the pending applications.
Because HOEKSTRA, JEFFREY GERBEN handles the total volume of 2 pending office actions, the prosecution strategy can be tailored specifically to the patterns of this individual. Practitioners can focus their resources on addressing the specific concerns of this 1 examiner rather than navigating multiple office perspectives. The concentration of 2 actions under 1 examiner in 1 art unit simplifies administrative tracking and allows for a cohesive argument across the pending matters. This arrangement means the portfolio's current filings are related in subject matter, requiring a response strategy to ensure consistent outcomes across the 2 pending actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 2 | 56.5% | +39.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915497 | Body Fluids Sampling Device and Method of using the Same | HOEKSTRA, JEFFREY GERBEN | 97d overdue |
| 18022772 | CAPILLARY BLOOD SAMPLING DEVICE AND METHOD OF USING THE SAME | HOEKSTRA, JEFFREY GERBEN | 48d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915497 | Body Fluids Sampling Device and Method of using the Same | HOEKSTRA, JEFFREY GERBEN | 97d overdue |
| 18022772 | CAPILLARY BLOOD SAMPLING DEVICE AND METHOD OF USING THE SAME | HOEKSTRA, JEFFREY GERBEN | 48d |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18022772 | CAPILLARY BLOOD SAMPLING DEVICE AND METHOD OF USING THE SAME | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§112 | Non-Final OA | 48d | Pending | Feb 23, 2023 |
| 17915497 | Body Fluids Sampling Device and Method of using the Same | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103§112 | Final Rejection | 97d overdue | Pending | Sep 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial